Equetro Interactions
There are 804 drugs known to interact with Equetro (carbamazepine), along with 13 disease interactions, and 1 alcohol/food interaction. Of the total drug interactions, 260 are major, 509 are moderate, and 35 are minor.
- View all 804 medications that may interact with Equetro
- View Equetro alcohol/food interactions (1)
- View Equetro disease interactions (13)
Most frequently checked interactions
View interaction reports for Equetro (carbamazepine) and the medicines listed below.
- Abilify (aripiprazole)
- Adderall (amphetamine / dextroamphetamine)
- albuterol
- aripiprazole
- bupropion
- buspirone
- Celexa (citalopram)
- clonazepam
- clonidine
- Cymbalta (duloxetine)
- gabapentin
- hydroxyzine
- Lamictal (lamotrigine)
- Latuda (lurasidone)
- levothyroxine
- lithium
- lorazepam
- Lyrica (pregabalin)
- melatonin
- montelukast
- omeprazole
- pantoprazole
- prednisone
- Seroquel (quetiapine)
- Synthroid (levothyroxine)
- trazodone
- Vitamin D3 (cholecalciferol)
- Vyvanse (lisdexamfetamine)
- Zoloft (sertraline)
- Zyrtec (cetirizine)
Equetro alcohol/food interactions
There is 1 alcohol/food interaction with Equetro (carbamazepine).
Equetro disease interactions
There are 13 disease interactions with Equetro (carbamazepine) which include:
- depression
- liver disease
- renal dysfunction
- blood dyscrasias
- history of porphyria
- hyponatremia
- suicidal tendency
- arrhythmias
- anticholinergic effects
- fructose intolerance
- psychosis
- seizures
- thyroid function tests
More about Equetro (carbamazepine)
- Equetro consumer information
- Compare alternatives
- Reviews (5)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: dibenzazepine anticonvulsants
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.